- Home
- CSTL vs CSIQ Comparison
CSTL vs CSIQ Comparison
Compare CSTL & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- CSIQ
- Stock Information
- Founded
- CSTL 2007
- CSIQ 2001
- Country
- CSTL United States
- CSIQ Canada
- Employees
- CSTL N/A
- CSIQ N/A
- Industry
- CSTL Medical Specialities
- CSIQ Semiconductors
- Sector
- CSTL Health Care
- CSIQ Technology
- Exchange
- CSTL Nasdaq
- CSIQ Nasdaq
- Market Cap
- CSTL 661.7M
- CSIQ 746.1M
- IPO Year
- CSTL 2019
- CSIQ 2006
- Fundamental
- Price
- CSTL $33.02
- CSIQ $28.28
- Analyst Decision
- CSTL Strong Buy
- CSIQ Hold
- Analyst Count
- CSTL 6
- CSIQ 8
- Target Price
- CSTL $38.67
- CSIQ $12.46
- AVG Volume (30 Days)
- CSTL 421.5K
- CSIQ 4.6M
- Earning Date
- CSTL 11-03-2025
- CSIQ 11-13-2025
- Dividend Yield
- CSTL N/A
- CSIQ N/A
- EPS Growth
- CSTL N/A
- CSIQ N/A
- EPS
- CSTL N/A
- CSIQ N/A
- Revenue
- CSTL $343,530,000.00
- CSIQ $5,919,361,000.00
- Revenue This Year
- CSTL N/A
- CSIQ N/A
- Revenue Next Year
- CSTL N/A
- CSIQ $24.59
- P/E Ratio
- CSTL N/A
- CSIQ N/A
- Revenue Growth
- CSTL 10.15
- CSIQ N/A
- 52 Week Low
- CSTL $14.59
- CSIQ $6.57
- 52 Week High
- CSTL $34.64
- CSIQ $28.50
- Technical
- Relative Strength Index (RSI)
- CSTL 81.56
- CSIQ 84.00
- Support Level
- CSTL $23.31
- CSIQ $20.71
- Resistance Level
- CSTL $34.36
- CSIQ $24.70
- Average True Range (ATR)
- CSTL 1.50
- CSIQ 1.85
- MACD
- CSTL 1.08
- CSIQ 1.21
- Stochastic Oscillator
- CSTL 89.19
- CSIQ 98.24
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.